HCW Biologics (HCWB) News Today → A ‘DeFi Summer’ Projected! (From Crypto 101 Media) (Ad) Free HCWB Stock Alerts $1.16 +0.01 (+0.87%) (As of 05/15/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 15 at 11:09 PM | investorplace.comHCWB Stock Earnings: HCW Biologics Reported Results for Q1 2024May 15 at 8:49 PM | marketwatch.comHCW Biologics Warns of Ability to Continue Operating Without Additional FundsMay 15 at 8:49 PM | markets.businessinsider.comHCW Biologics Reports First Quarter 2024 Financial Results and Business HighlightsMay 15 at 4:39 PM | globenewswire.comHCW Biologics Reports First Quarter 2024 Financial Results and Business HighlightsMay 15 at 4:29 AM | americanbankingnews.comHCW Biologics Inc. (NASDAQ:HCWB) Sees Significant Increase in Short InterestApril 2, 2024 | marketbeat.comHCW Biologics Inc. (NASDAQ:HCWB) Short Interest UpdateHCW Biologics Inc. (NASDAQ:HCWB - Get Free Report) was the target of a large drop in short interest in March. As of March 15th, there was short interest totalling 22,000 shares, a drop of 8.3% from the February 29th total of 24,000 shares. Based on an average daily volume of 16,700 shares, the days-to-cover ratio is presently 1.3 days. Currently, 0.1% of the company's stock are short sold.April 2, 2024 | investorplace.comHCWB Stock Earnings: HCW Biologics Misses EPS, Misses Revenue for Q4 2023April 1, 2024 | globenewswire.comHCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business HighlightsMarch 12, 2024 | marketbeat.comHCW Biologics Inc. (NASDAQ:HCWB) Sees Large Growth in Short InterestHCW Biologics Inc. (NASDAQ:HCWB - Get Free Report) was the recipient of a large increase in short interest during the month of February. As of February 29th, there was short interest totalling 24,000 shares, an increase of 445.5% from the February 14th total of 4,400 shares. Based on an average daily volume of 14,500 shares, the short-interest ratio is presently 1.7 days. Currently, 0.2% of the company's stock are sold short.February 24, 2024 | finance.yahoo.comRebecca Byam Bought 122% More Shares In HCW BiologicsJanuary 25, 2024 | finance.yahoo.comSeveral Insiders Invested In HCW Biologics Flagging Positive NewsNovember 17, 2023 | markets.businessinsider.comHCW Biologics Receives Buy Rating: Strong Financial Position and Promising Clinical Data Validate Investment OpportunityNovember 15, 2023 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: HCW Biologics (HCWB), Urogen Pharma (URGN)November 14, 2023 | finanznachrichten.deHCW Biologics, Inc: HCW Biologics Reports Third Quarter 2023 Financial Results And Recent Business HighlightsNovember 14, 2023 | msn.comHCW Biologics GAAP EPS of -$0.14, revenue of $174.77MNovember 14, 2023 | finance.yahoo.comHCW Biologics Reports Third Quarter 2023 Financial Results And Recent Business HighlightsNovember 11, 2023 | morningstar.comADMA Biologics Inc ADMANovember 11, 2023 | morningstar.comHCW Biologics Inc HCWBNovember 11, 2023 | markets.businessinsider.comPromising Phase 1 Results and Potential Synergies with PD-1 Inhibitors Bolster Buy Rating for HCW BiologicsNovember 8, 2023 | finance.yahoo.comInvestigator Sponsor of HCW Biologics’ Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual MeetingNovember 6, 2023 | finance.yahoo.comSamsung Biologics and Kurma Partners announce strategic partnership for development and manufacturing of biologics for Kurma's portfolio companiesNovember 1, 2023 | finance.yahoo.comMasonic Cancer Center, University of Minnesota to Present Data in Poster Presentation Human Data Readout for Phase 1 Study to Evaluate HCW9218 in Solid Tumors at SITC 38th Annual MeetingSeptember 21, 2023 | seekingalpha.comHCW Biologics director Gary Winer buys shares worth $3.3k - filingSeptember 16, 2023 | finance.yahoo.comInsider Buying: CFO Rebecca Byam Acquires 5,000 Shares of HCW Biologics IncSeptember 9, 2023 | finance.yahoo.comInsider Buying: CFO Rebecca Byam Acquires 10,000 Shares of HCW Biologics IncSeptember 6, 2023 | finance.yahoo.comHCW Biologics Participating at H.C. Wainwright 25th Annual Global Investment Conference in New York on September 11 – 13, 2023August 18, 2023 | finance.yahoo.comInsider Stock Buying Reaches US$845k On HCW BiologicsAugust 15, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: HCW Biologics (HCWB) and Cochlear Limited (OtherCHEOF)August 11, 2023 | finanznachrichten.deHCW Biologics, Inc: HCW Biologics Reports Second Quarter 2023 Financial Results and Recent Business HighlightsAugust 11, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: HCW Biologics (HCWB) and Arrowhead Pharmaceuticals (ARWR)August 11, 2023 | finance.yahoo.comHCW Biologics Reports Second Quarter 2023 Financial Results and Recent Business HighlightsJuly 7, 2023 | finance.yahoo.comThe past year for HCW Biologics (NASDAQ:HCWB) investors has not been profitableJuly 1, 2023 | finance.yahoo.comHCWB - HCW Biologics Inc.June 16, 2023 | benzinga.comDirector at HCW Biologics Acquires Company Stock Options Worth 12,500 SharesJune 14, 2023 | baystreet.caHCW Gains on Patent NewsJune 14, 2023 | technews.tmcnet.comHCW Biologics is Granted Third Fundamental Patent: U.S. Patent for Methods of Treating Age-Related DisordersJune 14, 2023 | finance.yahoo.comHCW Biologics is Granted Third Fundamental Patent: U.S. Patent for Methods of Treating Age-Related DisordersJune 9, 2023 | benzinga.comChief Financial Officer of HCW Biologics Purchased $51K In StockJune 8, 2023 | benzinga.comHCW Biologics Chief Financial Officer Trades Company's StockMay 10, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Syros Pharmaceuticals (SYRS) and HCW Biologics (HCWB)May 10, 2023 | finance.yahoo.comHCW Biologics First Quarter 2023 Earnings: US$0.14 loss per share (vs US$0.057 loss in 1Q 2022)May 9, 2023 | marketwatch.com10-Q: HCW BIOLOGICS INC.May 9, 2023 | msn.comRecap: HCW Biologics Q1 EarningsMay 9, 2023 | msn.comHCW Biologics: Q1 Earnings InsightsMay 9, 2023 | finanznachrichten.deHCW Biologics, Inc: HCW Biologics Reports First Quarter 2023 Financial Results And Recent Business HighlightsMay 9, 2023 | finance.yahoo.comHCW Biologics Reports First Quarter 2023 Financial Results And Recent Business HighlightsApril 27, 2023 | finance.yahoo.comHCW Biologics Secures $26.25 Million Non-Dilutive Financing With Asset-Backed Development LoanApril 19, 2023 | msn.comEF Hutton Reiterates HCW Biologics (HCWB) Buy RecommendationApril 13, 2023 | finance.yahoo.comHCW Biologics Poster Presentation at AACR Annual Meeting 2023April 5, 2023 | finanznachrichten.deHCW Biologics, Inc: A Novel Immunotherapeutic Approach to Treating Aging-Associated Diseases Get HCW Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for HCWB and its competitors with MarketBeat's FREE daily newsletter. Email Address The most important AI company you've never heard of (Ad)Because this small company solves the BIGGEST problem with Nvidia's AI chips. Already, Amazon, Microsoft, Google and others are lining up to get this company's products. Get the full story on this secret AI company poised for massive growth HCWB Media Mentions By Week HCWB Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HCWB News Sentiment▼0.390.55▲Average Medical News Sentiment HCWB News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HCWB Articles This Week▼70▲HCWB Articles Average Week Get HCW Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for HCWB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Rockwell Medical News Today Ocuphire Pharma News Today Clene News Today Xilio Therapeutics News Today Immuneering News Today Sensei Biotherapeutics News Today Aadi Bioscience News Today Gain Therapeutics News Today Lexaria Bioscience News Today NextCure News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HCWB) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersBiden to Drop BOMBSHELL June 13th?Paradigm PressAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market AlertsShocking $16T Elon Musk Crypto LeakCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HCW Biologics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
